These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 26807325)

  • 1. Noninvasive urinary miRNA biomarkers for early detection of pancreatic adenocarcinoma.
    Debernardi S; Massat NJ; Radon TP; Sangaralingam A; Banissi A; Ennis DP; Dowe T; Chelala C; Pereira SP; Kocher HM; Young BD; Bond-Smith G; Hutchins R; Crnogorac-Jurcevic T
    Am J Cancer Res; 2015; 5(11):3455-66. PubMed ID: 26807325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNAs in stool samples as potential screening biomarkers for pancreatic ductal adenocarcinoma cancer.
    Yang JY; Sun YW; Liu DJ; Zhang JF; Li J; Hua R
    Am J Cancer Res; 2014; 4(6):663-73. PubMed ID: 25520858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Global microRNA expression profiling of microdissected tissues identifies miR-135b as a novel biomarker for pancreatic ductal adenocarcinoma.
    Munding JB; Adai AT; Maghnouj A; Urbanik A; Zöllner H; Liffers ST; Chromik AM; Uhl W; Szafranska-Schwarzbach AE; Tannapfel A; Hahn SA
    Int J Cancer; 2012 Jul; 131(2):E86-95. PubMed ID: 21953293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel Circulating miRNA Signatures for Early Detection of Pancreatic Neoplasia.
    Vila-Navarro E; Duran-Sanchon S; Vila-Casadesús M; Moreira L; Ginès À; Cuatrecasas M; Lozano JJ; Bujanda L; Castells A; Gironella M
    Clin Transl Gastroenterol; 2019 Apr; 10(4):e00029. PubMed ID: 31009404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of differentially expressed microRNAs in serum of pancreatic ductal adenocarcinoma patients: miR-196a could be a potential marker for poor prognosis.
    Kong X; Du Y; Wang G; Gao J; Gong Y; Li L; Zhang Z; Zhu J; Jing Q; Qin Y; Li Z
    Dig Dis Sci; 2011 Feb; 56(2):602-9. PubMed ID: 20614181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A combination of urinary biomarker panel and PancRISK score for earlier detection of pancreatic cancer: A case-control study.
    Debernardi S; O'Brien H; Algahmdi AS; Malats N; Stewart GD; Plješa-Ercegovac M; Costello E; Greenhalf W; Saad A; Roberts R; Ney A; Pereira SP; Kocher HM; Duffy S; Blyuss O; Crnogorac-Jurcevic T
    PLoS Med; 2020 Dec; 17(12):e1003489. PubMed ID: 33301466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a Three-Biomarker Panel in Urine for Early Detection of Pancreatic Adenocarcinoma.
    Radon TP; Massat NJ; Jones R; Alrawashdeh W; Dumartin L; Ennis D; Duffy SW; Kocher HM; Pereira SP; Guarner posthumous L; Murta-Nascimento C; Real FX; Malats N; Neoptolemos J; Costello E; Greenhalf W; Lemoine NR; Crnogorac-Jurcevic T
    Clin Cancer Res; 2015 Aug; 21(15):3512-21. PubMed ID: 26240291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of miR-124 predicts poor prognosis in pancreatic ductal adenocarcinoma patients.
    Sun B; Liu X; Gao Y; Li L; Dong Z
    Br J Biomed Sci; 2016 Oct; 73(4):152-157. PubMed ID: 27922430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of a Circulating 2'-O-methylated MicroRNA Panel to the Diagnosis of Pancreatic Ductal Adenocarcinoma.
    Yang Z; Huang J; Wu X; Zhou Y; Tang Y; Zhu Y; Li B; Chen X; Yao W
    J Cancer; 2024; 15(6):1583-1592. PubMed ID: 38370369
    [No Abstract]   [Full Text] [Related]  

  • 10. miRNA-21 and miRNA-34a Are Potential Minimally Invasive Biomarkers for the Diagnosis of Pancreatic Ductal Adenocarcinoma.
    Alemar B; Izetti P; Gregório C; Macedo GS; Castro MA; Osvaldt AB; Matte U; Ashton-Prolla P
    Pancreas; 2016 Jan; 45(1):84-92. PubMed ID: 26262588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-3940-5p/miR-8069 ratio in urine exosomes is a novel diagnostic biomarker for pancreatic ductal adenocarcinoma.
    Yoshizawa N; Sugimoto K; Tameda M; Inagaki Y; Ikejiri M; Inoue H; Usui M; Ito M; Takei Y
    Oncol Lett; 2020 Apr; 19(4):2677-2684. PubMed ID: 32218818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome-scale analysis to identify prognostic microRNA biomarkers in patients with early stage pancreatic ductal adenocarcinoma after pancreaticoduodenectomy.
    Liao X; Wang X; Huang K; Yang C; Yu T; Han C; Zhu G; Su H; Huang R; Peng T
    Cancer Manag Res; 2018; 10():2537-2551. PubMed ID: 30127641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum miR-210-3p can be used to differentiate between patients with pancreatic ductal adenocarcinoma and chronic pancreatitis.
    Guz M; Jeleniewicz W; Cybulski M; Kozicka J; Kurzepa J; Mądro A
    Biomed Rep; 2021 Jan; 14(1):10. PubMed ID: 33235725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating microRNAs in Pancreatic Juice as Candidate Biomarkers of Pancreatic Cancer.
    Wang J; Raimondo M; Guha S; Chen J; Diao L; Dong X; Wallace MB; Killary AM; Frazier ML; Woodward TA; Wang J; Sen S
    J Cancer; 2014; 5(8):696-705. PubMed ID: 25258651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of A Panel of Serum microRNAs as Biomarkers for Early Detection of Lung Adenocarcinoma.
    Lv S; Xue J; Wu C; Wang L; Wu J; Xu S; Liang X; Lou J
    J Cancer; 2017; 8(1):48-56. PubMed ID: 28123597
    [No Abstract]   [Full Text] [Related]  

  • 16. MicroRNAs as diagnostic markers for pancreatic ductal adenocarcinoma and its precursor, pancreatic intraepithelial neoplasm.
    Xue Y; Abou Tayoun AN; Abo KM; Pipas JM; Gordon SR; Gardner TB; Barth RJ; Suriawinata AA; Tsongalis GJ
    Cancer Genet; 2013 Jun; 206(6):217-21. PubMed ID: 23933230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific MAPK-Associated MicroRNAs in Serum Differentiate Pancreatic Cancer from Autoimmune Pancreatitis.
    Akamatsu M; Makino N; Ikeda Y; Matsuda A; Ito M; Kakizaki Y; Saito Y; Ishizawa T; Kobayashi T; Furukawa T; Ueno Y
    PLoS One; 2016; 11(7):e0158669. PubMed ID: 27380024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pancreatic Juice Exosomal MicroRNAs as Biomarkers for Detection of Pancreatic Ductal Adenocarcinoma.
    Nakamura S; Sadakari Y; Ohtsuka T; Okayama T; Nakashima Y; Gotoh Y; Saeki K; Mori Y; Nakata K; Miyasaka Y; Onishi H; Oda Y; Goggins M; Nakamura M
    Ann Surg Oncol; 2019 Jul; 26(7):2104-2111. PubMed ID: 30820789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and Validation of Circulating Micrornas as Prognostic Biomarkers in Pancreatic Ductal Adenocarcinoma Patients Undergoing Surgical Resection.
    Gablo N; Trachtova K; Prochazka V; Hlavsa J; Grolich T; Kiss I; Srovnal J; Rehulkova A; Lovecek M; Skalicky P; Berindan-Neagoe I; Kala Z; Slaby O
    J Clin Med; 2020 Jul; 9(8):. PubMed ID: 32751582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pre-operative Plasma miR-21-5p Is a Sensitive Biomarker and Independent Prognostic Factor in Patients with Pancreatic Ductal Adenocarcinoma Undergoing Surgical Resection.
    Karasek P; Gablo N; Hlavsa J; Kiss I; Vychytilova-Faltejskova P; Hermanova M; Kala Z; Slaby O; Prochazka V
    Cancer Genomics Proteomics; 2018; 15(4):321-327. PubMed ID: 29976637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.